High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$289K
$289,295
Total Sells (Filtered)
$16.3M
$16,327,396
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
LENZ
M
LENZ Therapeutics, Inc.
Olsson Shawn
• Officer • Chief Commercial Officer
Other
2025-11-17
$20,800
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
Officer • Chief Commercial Officer
Other
|
2025-11-17 | $20,800 | M | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Olsson Shawn
• Officer • Chief Commercial Officer
10b5-1 SellΔOwn -28.6%
2025-11-17
$261,022x2
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
Officer • Chief Commercial Officer
10b5-1 SellΔOwn -28.6%
|
2025-11-17 | $261,022x2 | S | Form 4 |
|
LENZ
P
LENZ Therapeutics, Inc.
Chevallard Daniel R.
• CFO
Discretionary BuyΔOwn +67.9%
2025-11-07
$50,017x2
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
CFO
Discretionary BuyΔOwn +67.9%
|
2025-11-07 | $50,017x2 | P | Form 4 |
| LENZ |
LENZ Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-11-07 | $239,278 | P | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-30
$10,352,017MEGAx6
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-30 | $10,352,017MEGAx6 | S | Form 4 |
|
LENZ
S
LENZ Therapeutics, Inc.
Versant Venture Capital VI, L.P.
• 10% Owner
Discretionary Sell
2025-09-18
$5,714,356Whalex6
|
||||||
| LENZ |
LENZ Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-09-18 | $5,714,356Whalex6 | S | Form 4 |